Sugi Predict

Sugi Predict / Compounds / SCHEMBL5181745

SCHEMBL5181745

SCHEMBL5181745

COc1cc(C=C(O)c2ccccc2)cc(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 7/20 0.54
▸ MEN1 O00255 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ TRPV1 Q8NER1 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ PDE4A P27815 1/20 0.50
▸ PDE4B Q07343 1/20 0.50
▸ PDE4C Q08493 1/20 0.50
▸ PDE4D Q08499 1/20 0.50
▸ ABL1 P00519 2/20 0.47
▸ BCR P11274 2/20 0.47
▸ NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19433096 0.85 ALDH1A1 (0.50) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL19433094 0.85 ALDH1A1 (0.50) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL3808057 0.84 NQO2 (0.77) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL3808056 0.84 NQO2 (0.77) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL1650706 0.82 NQO2 (0.51) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL1650710 0.82 NQO2 (0.51) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL1651929 0.81 NQO2 (0.50) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL9858496 0.79 MAPT (0.58) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL17938786 0.79 TUBB1 (0.59) NQO2MEN1ALDH1A1KMT2AKDM4E
SCHEMBL1651931 0.78 NQO2 (0.47) NQO2MEN1ALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1796459-A2 FUNGICIDALLY ACTIVE POLYMER DISPERSIONS AND USE THEREOF Celanese Emulsions GmbH (DE) 2007-06-20 — — EP claimed
WO-2006034762-A2 FUNGICIDALLY ACTIVE POLYMER DISPERSIONS AND USE THEREOF CELANESE EMULSIONS GMBH (DE) 2006-04-06 — — WO claimed
US-11129781-B2 Agent for hair deforming treatment KAO CORPORATION (JP) 2021-09-28 — — US disclosed
US-11045402-B2 Hair cosmetic composition KAO CORPORATION (JP) 2021-06-29 — — US disclosed
US-10959925-B2 Hair cosmetic composition KAO CORPORATION (JP) 2021-03-30 — — US disclosed
EP-3228302-B1 HAIR DEFORMATION TREATMENT AGENT KAO CORP (JP) 2020-09-02 — — EP disclosed
CN-106999382-B Hair deforming agent 花王株式会社 2020-07-10 — — CN disclosed
CN-106999380-B Hair deforming agent 花王株式会社 2020-05-05 — — CN disclosed
US-20190290564-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2019-09-26 — — US disclosed
US-20190254943-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2019-08-22 — — US disclosed
US-20190224093-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2019-07-25 — — US disclosed
US-20180311129-A1 AGENT FOR HAIR DEFORMING TREATMENT KAO CORPORATION (JP) 2018-11-01 — — US disclosed
WO-2017207767-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2017-12-07 — — WO disclosed
WO-2017207768-A1 METHOD FOR TREATING HAIR KAO CORPORATION (JP) 2017-12-07 — — WO disclosed
WO-2017207799-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2017-12-07 — — WO disclosed
WO-2017207786-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2017-12-07 — — WO disclosed
EP-3228302-A1 HAIR DEFORMATION TREATMENT AGENT Kao Corporation (JP) 2017-10-11 — — EP disclosed
EP-3228300-A1 HAIR DEFORMATION TREATMENT AGENT Kao Corporation (JP) 2017-10-11 — — EP disclosed
CN-106999380-A Hair deforming agent 花王株式会社 2017-08-01 — — CN disclosed
CN-106999382-A Hair deformation process agent 花王株式会社 2017-08-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045402-B2 Hair cosmetic composition CUTA, GRHPR, POLR1C NQO2 3725/4885MEN1 1443/4885ALDH1A1 1188/4885
US-10959925-B2 Hair cosmetic composition CUTA, POLR1C, GRHPR NQO2 3090/4885MEN1 1687/4885ALDH1A1 932/4885
US-20190254943-A1 HAIR COSMETIC COMPOSITION CUTA, POLR1C, GRHPR NQO2 3090/4885MEN1 1687/4885ALDH1A1 932/4885
US-20180311129-A1 AGENT FOR HAIR DEFORMING TREATMENT COL1A1, COL2A1, GRHPR NQO2 3484/4885MEN1 1506/4885ALDH1A1 99/4885
US-20190224093-A1 HAIR COSMETIC COMPOSITION CUTA, GRHPR, POLR1C NQO2 3725/4885MEN1 1443/4885ALDH1A1 1188/4885
US-11129781-B2 Agent for hair deforming treatment GRHPR, SLC26A4, COL1A1 NQO2 1456/4885MEN1 1850/4885ALDH1A1 1297/4885
US-20190290564-A1 HAIR COSMETIC COMPOSITION GRHPR, POLR1C, TYR NQO2 2352/4885MEN1 1122/4885ALDH1A1 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback